Stockscreener 앱 받기
58.86
0.91%
0.54
전일 마감가:
$58.32
열려 있는:
$58.62
하루 거래량:
293.35K
Relative Volume:
0.31
시가총액:
$2.99B
수익:
$534.53M
순이익/손실:
$-11.45M
주가수익비율:
-244.13
EPS:
-0.2411
순현금흐름:
$48.28M
1주 성능:
+4.68%
1개월 성능:
+20.15%
6개월 성능:
+101.71%
1년 성능:
+56.85%
1일 변동 폭
$57.94
$59.69
1주일 범위
$55.66
$59.88
52주 변동 폭
$25.36
$59.88
Atricure Inc Stock (ATRC) Company Profile
명칭
Atricure Inc
전화
513-755-4100
주소
7555 INNOVATION WAY, MASON, OH
Compare ATRC vs ISRG, BDX, RMD, ALC, MDLN
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
ATRC
Atricure Inc
|
58.85 | 2.77B | 534.53M | -11.45M | 48.28M | -0.2411 |
ISRG
Intuitive Surgical Inc
|
401.85 | 130.41B | 11.03B | 3.16B | 3.22B | 8.7251 |
BDX
Becton Dickinson Co
|
181.76 | 48.44B | 21.37B | 1.41B | 3.07B | 3.9437 |
RMD
Resmed Inc
|
224.68 | 31.49B | 5.54B | 1.52B | 1.74B | 10.37 |
ALC
Alcon Inc
|
65.49 | 31.92B | 10.63B | 819.00M | 1.59B | 1.6577 |
MDLN
Medline Inc
|
33.64 | 28.54B | 29.14B | 1.07B | 1.05B | 1.1956 |
Atricure Inc Stock (ATRC) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2026-02-18 | 다운그레이드 | Oppenheimer | Outperform → Perform |
| 2026-02-11 | 다운그레이드 | JP Morgan | Overweight → Neutral |
| 2024-12-17 | 재개 | JP Morgan | Overweight |
| 2024-04-23 | 업그레이드 | Oppenheimer | Perform → Outperform |
| 2023-10-23 | 개시 | JMP Securities | Mkt Outperform |
| 2023-09-29 | 개시 | UBS | Buy |
| 2021-08-05 | 다운그레이드 | Oppenheimer | Outperform → Perform |
| 2020-12-18 | 재확인 | Needham | Buy |
| 2020-11-06 | 재확인 | Needham | Buy |
| 2020-04-07 | 개시 | Oppenheimer | Outperform |
| 2020-02-06 | 개시 | BTIG Research | Buy |
| 2020-01-24 | 재확인 | Needham | Buy |
| 2019-08-13 | 다운그레이드 | Northland Capital | Outperform → Market Perform |
| 2019-04-12 | 개시 | JP Morgan | Overweight |
| 2018-10-04 | 재확인 | Needham | Buy |
| 2018-08-02 | 재확인 | Needham | Buy |
| 2018-08-02 | 재확인 | Stifel | Buy |
| 2018-06-18 | 재확인 | Needham | Buy |
| 2018-04-27 | 재확인 | Needham | Buy |
| 2018-01-16 | 재확인 | Needham | Buy |
| 2017-11-02 | 재확인 | Needham | Buy |
| 2017-07-28 | 재확인 | Needham | Buy |
| 2017-05-30 | 재개 | Piper Jaffray | Overweight |
| 2016-06-30 | 재개 | JMP Securities | Mkt Outperform |
| 2015-10-28 | 재확인 | Needham | Buy |
| 2015-10-06 | 재확인 | Canaccord Genuity | Buy |
| 2015-10-06 | 재확인 | Needham | Buy |
모두보기
Atricure Inc 주식(ATRC)의 최신 뉴스
AtriCure Executive Stock Sale Analysis - Intellectia AI
AtriCure CTO Sells 3,657 Shares - Yahoo Finance
AtriCure CTO Salvatore Privitera sells $201,135 in shares By Investing.com - Investing.com Nigeria
AtriCure (ATRC) Chief Technical Officer Salvatore Privitera Sells 3,657 Shares - GuruFocus
Do Options Traders Know Something About AtriCure Stock We Don't? - Yahoo Finance
AtriCure CTO Salvatore Privitera sells $201,135 in shares - investing.com
AtriCure (ATRC) CTO discloses pre-set stock sale - Stock Titan
AtriCure, Inc. (ATRC) Hit a 52 Week High, Can the Run Continue? - Yahoo Finance
How Atricure Inc. (ATRC) Affects Rotational Strategy Timing - Stock Traders Daily
AtriCure (ATRC) Momentum Meets A Pricey Narrative On $47 Fair Value - simplywall.st
AtriCure CTO Privitera Sells 7,763 Shares at $52.50 Each (NASDAQ: ATRC) - Kalkine Media
AtriCure at Wells Fargo conference: growth and margins run ahead By Investing.com - Investing.com India
AtriCure CTO Salvatore Privitera Sells 7,763 Shares via 10b5-1 Trading Plan - Kalkine Media
Atricure CTO Salvatore Privitera sells $407,557 in stock By Investing.com - Investing.com South Africa
AtriCure Inc (ATRC) Chief Technical Officer Salvatore Privitera Sells 7,763 Shares - GuruFocus
Atricure CTO Salvatore Privitera sells $407,557 in stock - Investing.com
Atricure Insider Sold Shares Worth $407,558, According to a Recent SEC Filing - marketscreener.com
AtriCure (ATRC) CTO sells stock under preset plan - Stock Titan
Biotech Stocks At 52-Week HighsATTO, HALO, IKT, TVTX, ATRC - RTTNews
A Look at AtriCure Inc (ATRC) After 7.5% Gain -- GF Value $39.67 vs Price $52.59 - GuruFocus
ATRC Maintains by Needham -- Price Target Raised to $64.00 - GuruFocus
AtriCure Price Target Raised to $64.00/Share From $45.00 by Needham - Moomoo
Atricure stock hits 52-week high at $50.00 By Investing.com - Investing.com Nigeria
Atricure stock hits 52-week high at $50.00 - Investing.com
Needham raises AtriCure stock price target on trial outlook - Investing.com
Needham raises AtriCure stock price target on trial outlook By Investing.com - Investing.com Nigeria
AtriCure Inc. (ATRC) Financials – Balance Sheet, Profit & Loss, Cash Flow - valueresearchonline.com
Trading Systems Reacting to (ATRC) Volatility - Stock Traders Daily
AtriCure (ATRC) Slips 1.48% to $48.54 as Shares Navigate Key Trading RangeVolatility Skew - vinanet.vn
AtriCure Inc. (ATRC) Shareholding Pattern – Promoters, FIIs & DIIs - Value Research
Atrial Fibrillation Surgery Market Companies, Size & Trends 2026-2035 - Precedence Research
ATRC Maintained Overweight by Piper Sandler -- Price Target Rais - GuruFocus
Piper Sandler raises AtriCure stock price target on quality measure By Investing.com - Investing.com Nigeria
Piper Sandler Maintains AtriCure(ATRC.US) With Buy Rating, Raises Target Price to $60 - moomoo.com
AtriCure chief legal officer sells $458,099 in stock By Investing.com - Investing.com Nigeria
Atricure Insider Sold Shares Worth $458,099, According to a Recent SEC Filing - marketscreener.com
Atrial Fibrillation Treatment Devices Market Trends and Forecast, 2035 | Includes Profiles of Abbott, AtriCure, Boston Scientific, Johnson & Johnson, and Medtronic - Yahoo Finance
AtriCure to Participate in the 2026 Wells Fargo Health Care Conference - Yahoo Finance
BTIG raises AtriCure stock price target on new quality metric By Investing.com - Investing.com Canada
BTIG raises AtriCure stock price target on new quality metric - Investing.com
AtriCure (ATRC) Financial Results: Profit Per Share Clears Its Benchmark in the Latest Session - vinanet.vn
A Look at AtriCure Inc (ATRC) After 3.0% Gain -- GF Value $39.53 vs Price $48.98 - GuruFocus
AtriCure stock hits 52-week high at 48.47 USD By Investing.com - Investing.com Nigeria
AtriCure stock hits 52-week high at 48.47 USD - Investing.com
AtriCure Stock: Promising Cardiovascular Surgical Platform (NASDAQ:ATRC) - Seeking Alpha
Advisors Capital Management LLC Takes Position in AtriCure, Inc. $ATRC - MarketBeat
Atricure Inc (ATRC) 재무 분석
매출
순이익
현금흐름
주당 순 이익
3.78%
자본화:
|
볼륨(24시간):